Showing results (1-10 of 1,550) with videos related to
Sort By:
Pageof 155
Radiation Research|March 1, 1994
Protection from lethal irradiation by the combination of stem cell factor and tempolJ Liebmann, A M DeLuca, A Epstein, et al.Cancer Research|July 1, 1994
In vivo radiation protection by nitric oxide modulationJ Liebmann, A M DeLuca, D Coffin, et al.Free Radical Biology & Medicine|September 18, 1999
Hemodynamic effect of the nitroxide superoxide dismutase mimicsS M Hahn, F J Sullivan, A M DeLuca, et al.International Journal of Radiation Oncology, Biology, Physics|August 1, 1984
The use of halogenated thymidine analogs as clinical radiosensitizers: rationale, current status, and future prospects: non-hypoxic cell sensitizersT J Kinsella, J B Mitchell, A Russo, et al.Cancer Research|October 1, 1985
Specific killing of human melanoma cells by 125I-labeled 9.2.27 monoclonal antibodyT Lindmo, E Boven, J B Mitchell, et al.Biochemistry. Biokhimiia|August 29, 1998
The role of nitric oxide chemistry in cancer treatmentD A Wink, Y Vodovotz, J A Cook, et al.The Journal of Clinical Investigation|November 1, 1983
Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibodyG Morstyn, S M Hsu, T Kinsella, et al.Experimental Hematology|May 1, 1985
In vivo incorporation of bromodeoxyuridine into proliferating cells in the marrow and its effects on granulocyte-macrophage progenitor cellsG Morstyn, T Kinsella, C S Shan, et al.Journal of the National Cancer Institute|October 1, 1984
Heterogeneity in the radiation survival curves and biochemical properties of human lung cancer cell linesG Morstyn, A Russo, D N Carney, et al.International Journal of Radiation Oncology, Biology, Physics|June 15, 1994
Changes in radiation survival curve parameters in human tumor and rodent cells exposed to paclitaxel (Taxol)J Liebmann, J A Cook, J Fisher, et al.Pageof 155